Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic

Journal of Antimicrobial Chemotherapy(2025)10.1093/jac/dkaf346Source: DataRank Database

Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic is a research paper published in Journal of Antimicrobial Chemotherapy (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.00)OA: closedTopics (38)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Eleanor E. Friedman ORCID,Christopher Kaperak,Paul Djuricich,Alicia Dawdani,Sophie Plotkin

Live enrichment

PubMed:40981754 OpenAlex:https://openalex.org/W4414383189

National Institutes of Health

Grant: R01 MH123396

National Institute of Allergy and Infectious Diseases

Grant: K24 AI167805

French Society of Infectious Diseases

Maladies Infectieuses Emergentes

ANRS

Société de Pathologie Infectieuse de Langue Française

SPILF

French Society of Infectious Diseases

Maladies Infectieuses Emergentes

ANRS

SPILF

Société de Pathologie Infectieuse de Langue Française

FWCI

0.00

Citation Percentile

0.3%

closedLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

publisherhttps://academic.oup.com/jac/article-pdf/80/11/3092/64344799/dkaf346.pdf

journalhttps://doi.org/10.1093/jac/dkaf346

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40981754

Fields of Study

HIV, Drug Use, Sexual RiskHIV-related health complications and treatmentsHIV/AIDS Research and InterventionsHumansFemaleHIV InfectionsMaleRetrospective StudiesMiddle AgedRilpivirineAnti-HIV AgentsAdultPyridonesHIV-1ChicagoInjectionsPractice Patterns, Physicians'Diketopiperazines

MeSH Terms

RilpivirineAdultChicagoFemaleHumansInjectionsMaleMiddle AgedPractice Patterns, Physicians'PyridonesRetrospective StudiesHIV-1HIV InfectionsAnti-HIV AgentsDiketopiperazines

Keywords

Human immunodeficiency virus (HIV)Antiretroviral therapySidaMEDLINECross-sectional study

Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic

FAIR Checklist

Authors (11)

Funding (12 grants)

Impact

Open Access

Topics